Drug Type Monoclonal antibody |
Synonyms MM 401 (Merrimack Pharmaceuticals), MM401 |
Target |
Mechanism MLL1 inhibitors(lysine methyltransferase 2A inhibitors), WDR5 inhibitors(WD repeat-containing protein 5 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | - |